SCCM2023EN
Guidelines for the Administration of Neuromuscular Blockade in Adults With ARDS
Zusammenfassung
Society of Critical Care Medicine Guidelines for the Administration of Neuromuscular Blockade in Adults With Acute Respiratory Distress Syndrome.
RATIONALE: Neuromuscular blocking agents (NMBAs) show potential benefits on mortality and other complications of acute respiratory distress syndrome (ARDS) in adult patients. Evidence-based decisions and processes ensure appropriate use of neuromuscular blockade in adult patients with ARDS.
OBJECTIVES: The objective of these guidelines was to develop
Kerninformationen
ons. One recommendation is to use NMBAs in adults with ARDS with Pao2/Fio2 less than 150. For the other recommendations, there was equipoise in the recommendation for and against using titratable vs. fixed-dose NMBA dosing, a monitoring-based strategy for assessing depth of sedation and analgesia in...
guidelines provide additional perspectives on the use of NMBA in patients with ARDS, recognizing that institutional and patient-specific considerations must help to guide the decision-making process.
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
StatPearls2026
StatPearls: Nondepolarizing Neuromuscular Blockers
ESICM2023
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
StatPearls2026
StatPearls: Neuromuscular Blockade
StatPearls2026
StatPearls: Depolarizing Neuromuscular Blocking Drugs
StatPearls2026